-
Je něco špatně v tomto záznamu ?
What Can We Learn from Epidemiological Studies in Inflammatory Bowel Disease
D. Duricova,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
PubMed
28147360
DOI
10.1159/000449086
Knihovny.cz E-zdroje
- MeSH
- biologická terapie statistika a číselné údaje MeSH
- Crohnova nemoc * komplikace terapie MeSH
- dospělí MeSH
- epidemiologické studie * MeSH
- imunosupresiva terapeutické užití MeSH
- kolektomie statistika a číselné údaje MeSH
- kolorektální nádory * etiologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- riziko MeSH
- senioři MeSH
- ulcerózní kolitida * komplikace terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Population-based studies represent the whole spectrum of patient population and should represent the mainstay when evaluating patients' prognosis. A high number of CD patients need surgical intervention during the disease course. The disease course of inflammatory bowel diseases, including ulcerative colitis (UC) and Crohn's disease (CD), is quite varied and still quite unpredictable. Key Messages: According to earlier studies, up to 60% of patients undergo at least one operation after 10 years of CD duration. Newer cohorts report lower cumulative probability of surgery of approximately 40% after 10 years. The colectomy rate in UC is approximately 10% after 10 years from diagnosis with a geographic difference. Similarly to CD, the colectomy rate seems to decrease over time. There is some evidence that the increasing use of immunosuppressive and/or biological therapy might have been responsible for this favourable trend. However, other factors may have an impact on decreasing surgical trend over time. The relative risk (RR) of colorectal cancer (CRC) in UC is approximately doubled compared to background population. However, the absolute risk in general is relatively low between 1.1 and 5.3% after 20 years of disease duration. Furthermore, a decreasing trend in the incidence of CRC has been reported in recent studies. Importantly, several factors such as disease extent, activity, age at UC onset, and so on may increase/modify an individual risk. Similar to UC, CD patients have approximately 2 times higher RR of cancer compared to background population. The risk is higher for colon than for rectum cancer and present only in CD patients with colonic involvement. CONCLUSIONS: The surgery rate in CD has decreased over the time period. The evidence on colectomy rate in UC is less conclusive. The RR of CRC in UC and CD is approximately doubled compared to that of the background population, but it seems to be decreasing in more recent cohorts.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013279
- 003
- CZ-PrNML
- 005
- 20170428121513.0
- 007
- ta
- 008
- 170413s2017 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000449086 $2 doi
- 035 __
- $a (PubMed)28147360
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Duricova, Dana $u IBD Clinical and Research Centre, ISCARE, Prague, Czech Republic.
- 245 10
- $a What Can We Learn from Epidemiological Studies in Inflammatory Bowel Disease / $c D. Duricova,
- 520 9_
- $a BACKGROUND: Population-based studies represent the whole spectrum of patient population and should represent the mainstay when evaluating patients' prognosis. A high number of CD patients need surgical intervention during the disease course. The disease course of inflammatory bowel diseases, including ulcerative colitis (UC) and Crohn's disease (CD), is quite varied and still quite unpredictable. Key Messages: According to earlier studies, up to 60% of patients undergo at least one operation after 10 years of CD duration. Newer cohorts report lower cumulative probability of surgery of approximately 40% after 10 years. The colectomy rate in UC is approximately 10% after 10 years from diagnosis with a geographic difference. Similarly to CD, the colectomy rate seems to decrease over time. There is some evidence that the increasing use of immunosuppressive and/or biological therapy might have been responsible for this favourable trend. However, other factors may have an impact on decreasing surgical trend over time. The relative risk (RR) of colorectal cancer (CRC) in UC is approximately doubled compared to background population. However, the absolute risk in general is relatively low between 1.1 and 5.3% after 20 years of disease duration. Furthermore, a decreasing trend in the incidence of CRC has been reported in recent studies. Importantly, several factors such as disease extent, activity, age at UC onset, and so on may increase/modify an individual risk. Similar to UC, CD patients have approximately 2 times higher RR of cancer compared to background population. The risk is higher for colon than for rectum cancer and present only in CD patients with colonic involvement. CONCLUSIONS: The surgery rate in CD has decreased over the time period. The evidence on colectomy rate in UC is less conclusive. The RR of CRC in UC and CD is approximately doubled compared to that of the background population, but it seems to be decreasing in more recent cohorts.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a biologická terapie $x statistika a číselné údaje $7 D001691
- 650 _2
- $a kolektomie $x statistika a číselné údaje $7 D003082
- 650 12
- $a ulcerózní kolitida $x komplikace $x terapie $7 D003093
- 650 12
- $a kolorektální nádory $x etiologie $7 D015179
- 650 12
- $a Crohnova nemoc $x komplikace $x terapie $7 D003424
- 650 12
- $a epidemiologické studie $7 D016021
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunosupresiva $x terapeutické užití $7 D007166
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a riziko $7 D012306
- 655 _2
- $a časopisecké články $7 D016428
- 773 0_
- $w MED00173707 $t Digestive diseases (Basel, Switzerland) $x 1421-9875 $g Roč. 35, č. 1-2 (2017), s. 69-73
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28147360 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170428121835 $b ABA008
- 999 __
- $a ok $b bmc $g 1199744 $s 974057
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 35 $c 1-2 $d 69-73 $e 20170201 $i 1421-9875 $m Digestive diseases $n Dig Dis $x MED00173707
- LZP __
- $a Pubmed-20170413